BNP Paribas Financial Markets Purchases 1,011 Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG)

BNP Paribas Financial Markets grew its position in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 5.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 21,329 shares of the company’s stock after acquiring an additional 1,011 shares during the period. BNP Paribas Financial Markets’ holdings in BrightSpring Health Services were worth $313,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. nVerses Capital LLC acquired a new stake in BrightSpring Health Services in the second quarter valued at $55,000. California State Teachers Retirement System acquired a new stake in BrightSpring Health Services in the first quarter valued at $59,000. Charles Schwab Investment Management Inc. increased its holdings in BrightSpring Health Services by 1.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 440,335 shares of the company’s stock valued at $6,464,000 after purchasing an additional 6,326 shares during the period. Intech Investment Management LLC acquired a new stake in BrightSpring Health Services during the 3rd quarter worth about $159,000. Finally, The Manufacturers Life Insurance Company grew its holdings in BrightSpring Health Services by 10.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 117,026 shares of the company’s stock worth $1,329,000 after acquiring an additional 10,854 shares during the period.

Analyst Ratings Changes

BTSG has been the subject of a number of recent analyst reports. KeyCorp initiated coverage on BrightSpring Health Services in a report on Friday, October 11th. They set a “sector weight” rating for the company. CJS Securities initiated coverage on BrightSpring Health Services in a report on Thursday. They set an “outperform” rating and a $27.00 price target for the company. Bank of America increased their price target on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. BTIG Research increased their price target on BrightSpring Health Services from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Finally, Guggenheim increased their price target on BrightSpring Health Services from $15.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, BrightSpring Health Services presently has a consensus rating of “Moderate Buy” and an average target price of $18.50.

BrightSpring Health Services Price Performance

Shares of NASDAQ BTSG opened at $18.56 on Monday. BrightSpring Health Services, Inc. has a fifty-two week low of $7.85 and a fifty-two week high of $20.25. The stock has a market cap of $3.23 billion and a price-to-earnings ratio of -71.38. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The firm’s 50-day simple moving average is $17.49 and its 200 day simple moving average is $14.08.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings results on Friday, November 1st. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.07). BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The business had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.72 billion. The firm’s revenue for the quarter was up 28.8% on a year-over-year basis. As a group, research analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.